Accidental Ingestion of Extended-Release Guanfacine in a Toddler
Dina R Assali1, Alek Q Adkins2, Jonathan Chang3
1Emergency Department, OhioHealth Doctors Hospital, Columbus, USA.
Insights
This case report details a toddler
Area of Science:
- Pharmacology
- Toxicology
- Pediatrics
Background:
- Guanfacine, an alpha-2a agonist, is used to treat conditions like ADHD.
- Its mechanism involves central nervous system (CNS) effects, typically causing depression, hypotension, and bradycardia.
Observation:
- A healthy toddler experienced exploratory ingestion of extended-release (ER) guanfacine.
- The patient presented with persistent hypertension, a rare and severe adverse effect.
Findings:
- Persistent hypertension required intravenous vasodilatory medication.
- This highlights a rare, life-threatening complication of alpha-2 agonist exposure in children.
Implications:
- Clinicians should be aware of the potential for severe hypertension following guanfacine overdose.
- This case expands the literature on rare adverse effects of alpha-2 agonists in pediatric populations.
Abstract:
This case report describes the clinical presentation and treatment following an exploratory ingestion of extended release (ER) guanfacine in a healthy toddler. Guanfacine, an alpha-2a agonist, can cause transient hypertension as it moves from the serum into the CNS where it causes the more commonly seen central nervous system (CNS) depression, hypotension, and bradycardia. Persistent hypertension requiring intravenous (IV) vasodilatory medication is a rare and life-threatening complication of an alpha-2 agonist with only one other published report. This case report re-emphasizes and further expands available literature on this rarely reported effect.
More Related Videos
09:04A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Factors Affecting Drug Response: Overview
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drug Delivery: Enteral Route
Prevention of Further Absorption of Poison
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
